ChipIdea Contributes for Customer Success on Mobile Camera Solutions
Update: MIPS Technologies Acquires Chipidea (August 27, 2007)
Porto Salvo-August 21, 2003 - ChipIdea has successfully completed the development of new data conversion IP cores for application in VGA cameras for mobile communications with resolution of 640x480 pixels.
In cooperation with TransChip, a fabless semiconductor company whose line of business is the design of advanced CMOS imagers for mobile communication devices, ChipIdea has developed a dual 10bit 4MS/s ADC together with a wide range of voltage regulators to deliver the power to all the circuitry inside the chip. This also allowed TransChip to implement an advanced power management scheme with very low power dissipation in sleep mode.
|
||||||
Related News
- Cadence Collaborates with Arm to Accelerate Mobile Device Silicon Success with New Arm Total Compute Solutions
- Cadence Expands Collaboration with Arm to Accelerate Mobile Device Silicon Success
- Synopsys Enables Tapeout Success for Early Adopters of Arm's Next Generation of Mobile IP
- T2M announces its first Image Signal Processing (ISP) Technology for advanced mobile camera applications
- Synopsys Enables Tapeout Success for Early Adopters of Arm's Latest Premium Mobile IP, Including Cortex-A76 and Mali-G76 Processors
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
|
|
E-mail This Article |
|
Printer-Friendly Page |






